The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[5-({3-[5-(Acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-{5-[2-(3,5-dimethyl-adamantan-1-yl)-acetylamino]-pentyl}-N'-hydroxy-succinamide ID: ALA4210466
Chembl Id: CHEMBL4210466
PubChem CID: 145963844
Max Phase: Preclinical
Molecular Formula: C39H68N6O9
Molecular Weight: 765.01
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CC12CC3CC(C)(CC(C)(C3)C1)C2
Standard InChI: InChI=1S/C39H68N6O9/c1-30(46)43(52)20-10-4-7-17-40-32(47)13-15-35(50)44(53)21-11-5-8-18-41-33(48)14-16-36(51)45(54)22-12-6-9-19-42-34(49)26-39-25-31-23-37(2,28-39)27-38(3,24-31)29-39/h31,52-54H,4-29H2,1-3H3,(H,40,47)(H,41,48)(H,42,49)
Standard InChI Key: QIWTWOZMQZRBET-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 765.01Molecular Weight (Monoisotopic): 764.5048AlogP: 4.47#Rotatable Bonds: 26Polar Surface Area: 208.92Molecular Species: NEUTRALHBA: 9HBD: 6#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 7.92CX Basic pKa: ┄CX LogP: 0.93CX LogD: 0.81Aromatic Rings: ┄Heavy Atoms: 54QED Weighted: 0.04Np Likeness Score: 0.01
References 1. Telfer TJ, Liddell JR, Duncan C, White AR, Codd R.. (2017) Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease., 27 (8): [PMID:28285915 ] [10.1016/j.bmcl.2017.03.001 ]